BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 28467901)

  • 1. Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin.
    Jiang Y; Marinescu VD; Xie Y; Jarvius M; Maturi NP; Haglund C; Olofsson S; Lindberg N; Olofsson T; Leijonmarck C; Hesselager G; Alafuzoff I; Fryknäs M; Larsson R; Nelander S; Uhrbom L
    Cell Rep; 2017 May; 19(5):1080-1081. PubMed ID: 28467901
    [No Abstract]   [Full Text] [Related]  

  • 2. Glioblastoma Cell Malignancy and Drug Sensitivity Are Affected by the Cell of Origin.
    Jiang Y; Marinescu VD; Xie Y; Jarvius M; Maturi NP; Haglund C; Olofsson S; Lindberg N; Olofsson T; Leijonmarck C; Hesselager G; Alafuzoff I; Fryknäs M; Larsson R; Nelander S; Uhrbom L
    Cell Rep; 2017 Jan; 18(4):977-990. PubMed ID: 28122246
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomolecular characterization of human glioblastoma cells in primary cultures: differentiating and antiangiogenic effects of natural and synthetic PPARgamma agonists.
    Benedetti E; Galzio R; Cinque B; Biordi L; D'Amico MA; D'Angelo B; Laurenti G; Ricci A; Festuccia C; Cifone MG; Lombardi D; Cimini A
    J Cell Physiol; 2008 Oct; 217(1):93-102. PubMed ID: 18446822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of the biophysical features of a 3D gelatin microenvironment on glioblastoma malignancy.
    Pedron S; Harley BA
    J Biomed Mater Res A; 2013 Dec; 101(12):3404-15. PubMed ID: 23559545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fumonisin B1-induced apoptosis in neuroblastoma, glioblastoma and hypothalamic cell lines.
    Stockmann-Juvala H; Naarala J; Loikkanen J; Vähäkangas K; Savolainen K
    Toxicology; 2006 Aug; 225(2-3):234-41. PubMed ID: 16860453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interindividual differences in anticancer drug cytotoxicity in primary human glioblastoma cells.
    Pédeboscq S; L'Azou B; Liguoro D; Pometan JP; Cambar J
    Exp Toxicol Pathol; 2007 Jan; 58(4):247-53. PubMed ID: 17123803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptotic effect of atorvastatin in glioblastoma spheroids tumor cultured in fibrin gel.
    Bayat N; Ebrahimi-Barough S; Norouzi-Javidan A; Saberi H; Tajerian R; Ardakan MMM; Shirian S; Ai A; Ai J
    Biomed Pharmacother; 2016 Dec; 84():1959-1966. PubMed ID: 27836464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The sodium pump could constitute a new target to combat glioblastomas].
    Lefranc F; Mijatovic T; Kiss R
    Bull Cancer; 2008 Mar; 95(3):271-81. PubMed ID: 18390407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HDAC inhibitors effectively induce cell type-specific differentiation in human glioblastoma cell lines of different origin.
    Svechnikova I; Almqvist PM; Ekström TJ
    Int J Oncol; 2008 Apr; 32(4):821-7. PubMed ID: 18360709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oct-3/4 modulates the drug-resistant phenotype of glioblastoma cells through expression of ATP binding cassette transporter G2.
    Hosokawa Y; Takahashi H; Inoue A; Kawabe Y; Funahashi Y; Kameda K; Sugimoto K; Yano H; Harada H; Kohno S; Ohue S; Ohnishi T; Tanaka J
    Biochim Biophys Acta; 2015 Jun; 1850(6):1197-205. PubMed ID: 25644290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antagonist activity of the antipsychotic drug lithium chloride and the antileukemic drug imatinib mesylate during glioblastoma treatment in vitro.
    Aras Y; Erguven M; Aktas E; Yazihan N; Bilir A
    Neurol Res; 2016 Sep; 38(9):766-74. PubMed ID: 27367429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia induces peroxisome proliferator-activated receptor α (PPARα) and lipid metabolism peroxisomal enzymes in human glioblastoma cells.
    Laurenti G; Benedetti E; D'Angelo B; Cristiano L; Cinque B; Raysi S; Alecci M; Cerù MP; Cifone MG; Galzio R; Giordano A; Cimini A
    J Cell Biochem; 2011 Dec; 112(12):3891-901. PubMed ID: 21866563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol sensitizes glioblastoma-initiating cells to temozolomide by inducing cell apoptosis and promoting differentiation.
    Li H; Liu Y; Jiao Y; Guo A; Xu X; Qu X; Wang S; Zhao J; Li Y; Cao Y
    Oncol Rep; 2016 Jan; 35(1):343-51. PubMed ID: 26498391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synergistic interactions between camptothecin and EGFR or RAC1 inhibitors and between imatinib and Notch signaling or RAC1 inhibitors in glioblastoma cell lines.
    Sooman L; Ekman S; Andersson C; Kultima HG; Isaksson A; Johansson F; Bergqvist M; Blomquist E; Lennartsson J; Gullbo J
    Cancer Chemother Pharmacol; 2013 Aug; 72(2):329-40. PubMed ID: 23736154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glioblastoma cancer stem cells: heterogeneity, microenvironment and related therapeutic strategies.
    Denysenko T; Gennero L; Roos MA; Melcarne A; Juenemann C; Faccani G; Morra I; Cavallo G; Reguzzi S; Pescarmona G; Ponzetto A
    Cell Biochem Funct; 2010 Jul; 28(5):343-51. PubMed ID: 20535838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The aryl hydrocarbon receptor links integrin signaling to the TGF-β pathway.
    Silginer M; Burghardt I; Gramatzki D; Bunse L; Leske H; Rushing EJ; Hao N; Platten M; Weller M; Roth P
    Oncogene; 2016 Jun; 35(25):3260-71. PubMed ID: 26500056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase of BCNU sensitivity by wt-p53 gene therapy in glioblastoma lines depends on the administration schedule.
    Biroccio A; Bufalo DD; Ricca A; D'Angelo C; D'Orazi G; Sacchi A; Soddu S; Zupi G
    Gene Ther; 1999 Jun; 6(6):1064-72. PubMed ID: 10455409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of protease-activated receptor type 1 (PAR-1) in glioblastoma multiforme WHO IV cells and blood vessels revealed by NCAM-assisted glioblastoma border labeling.
    Kuhn SA; Martin M; Brodhun M; Kratzsch T; Hanisch UK; Haberl H
    Neurol Res; 2014 Aug; 36(8):709-21. PubMed ID: 24620969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet-derived growth factor receptor independent proliferation of human glioblastoma cells: selective tyrosine kinase inhibitors lack antiproliferative activity.
    Gross D; Bernhardt G; Buschauer A
    J Cancer Res Clin Oncol; 2006 Sep; 132(9):589-99. PubMed ID: 16736141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SP100 reduces malignancy of human glioma cells.
    Held-Feindt J; Hattermann K; Knerlich-Lukoschus F; Mehdorn HM; Mentlein R
    Int J Oncol; 2011 Apr; 38(4):1023-30. PubMed ID: 21274506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.